Back to search

Article

Clinical outcomes associated with Omicron (B.1.1.529) variant and BA.1/BA.1.1 or BA.2 subvariant infection in southern California

2022-01-11

Abstract excerpt

The Omicron (B.1.1.529) variant of SARS-CoV-2 rapidly achieved global dissemination following its emergence in southern Africa in November, 2021. 1,2 Epidemiologic surveillance has revealed changes in COVID-19 case-to-hospitalization and case-to-mortality ratios following Omicron variant emergence, 3–6 although interpretation of these changes presents challenges due to differential protection against Omicron or...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
34c55d23-d749-5052-b930-625e99ddd2b1
DOI
10.1101/2022.01.11.22269045
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Clinical outcomes associated with Omicron (B.1.1.529) variant and BA.1/BA.1.1 or BA.2 subvariant infection in southern CaliforniaDOI 10.1101/2022.01.11.22269045
Clinical phenotypes and outcomes associated with SARS-CoV-2 variant Omicron, sublineages BA.1, BA.1.1, BA.2 and impact of mutational patterns in critically ill French patients with COVID-19Semantic proximity
Risk of severe outcomes among Omicron sub-lineages BA.4.6, BA.2.75 and BQ.1 compared to BA.5 in EnglandSemantic proximity
Omicron (BA.1) SARS-CoV-2 variant is associated with reduced risk of hospitalization and length of stay compared with Delta (B.1.617.2)Semantic proximity
Omicron (BA.1) SARS-CoV-2 Variant Is Associated With Reduced Risk of Hospitalization and Length of Stay Compared With Delta (B.1.617.2)Semantic proximity
Hospitalisation and mortality risk of SARS-COV-2 variant omicron sub-lineage BA.2 compared to BA.1 in EnglandSemantic proximity
SARS-CoV-2 B.1.1.529 (Omicron) Variant - United States, December 1-8, 2021.Semantic proximity
Clinical Characteristics and Outcomes of Laboratory-Confirmed SARS-CoV-2 Cases Infected With Omicron Subvariants and the XBB Recombinant VariantSemantic proximity
Genomic Surveillance for SARS-CoV-2 Variants: Circulation of Omicron Lineages — United States, January 2022–May 2023Semantic proximity
Occurrence and significance of Omicron BA.1 infection followed by BA.2 reinfectionSemantic proximity
Genomic Surveillance for SARS-CoV-2 Variants: Circulation of Omicron XBB and JN.1 Lineages — United States, May 2023–September 2024Semantic proximity
Clinical Characteristics and Outcomes of Laboratory-Confirmed SARS-CoV-2 Cases Infected with Omicron subvariants and XBB recombinant variantSemantic proximity
Clinical phenotypes and outcomes associated with SARS-CoV-2 variant Omicron in critically ill French patients with COVID-19.Semantic proximity
Select a neighboring publication to make it the new centre.